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Aspartoacylase/aminoacylase II (ASPA/ACY II) is mainly synthesized in oligodendrocytes to contribute in myelin synthesis.
Although axonal damage is seen in the brain with human immunodeﬁciency virus encephalitis (HIVE), ASPA contribution in
the pathology is not known. Immunostaining study showed that ASPA protein is reduced in the white matter of patients with
HIVE compared to the control. Western blot study further conﬁrmed ASPA deﬁciency in the HIVE brain compared to the control.
This paper suggests that HIVE condition aﬀects ASPA to contribute in myelin loss/axonal damage seen in the disease.
1.Introduction
Human aspartoacylase/aminoacylase II (ASPA/ACY II; EC
no. 3.5.1.15) gene contains ﬁve introns and six exons
[1, 2]. Normal level of its substrate, N-acetylaspartic acid
(NAA/NA-Asp) is important for the maintenance of healthy
neurons. Altered levels of the NAA contribute in disease
pathophysiology by inducing oxidative stress and by sup-
pressing potential antioxidants [3–6]. Abnormal level of this
pathway contributes in various diseases including Canavan
disease[1–4],type2diabetes[7],andParkinson’sdisease[8].
Aspartoacylase is mainly synthesized in oligodendrocytes to
contribute in myelin synthesis [1, 2].
Humanimmunodeﬁciencyvirusencephalitis(HIVE)isa
demyelinating disease of the central nervous system, caused
by the lethal virus [9–11]. Approximately 2.7 million new
HIV-1 infections and 2.0 million deaths due to AIDS were
reported in 2008 [12, 13]. In North America, the epidemic is
expanding in the population among men who have sex with
men [14, 15]. Brain regions aﬀected in the disease include
basal ganglia and deep white matter [16, 17], and these brain
regions are also aﬀected in the brain with Canavan disease
[1, 2], therefore studying aspartoacylase level in the white
matter of the patients with HIVE is important. Thus, the
present study was aimed to understand ASPA level in the
white matter of patients HIVE.
2.MaterialsandMethods
Six brain samples each from control and HIVE were used.
While control brains showed no histologic abnormalities,
HIVE brain showed leucoencephalopathy. All the procedures
were performed under the regulations of institutional ethical
committee and with the Helsinki Declaration of 1975, as
revised in 2000 (World Medical Association Declaration
of Helsinki 2000). To perform immunostaining, paraﬃn
sections from three each of control and HIVE brain were
deparaﬃnized in xylene, rehydrated in graded ethanol and
incubated with ASPA antibody (Santacruz, CA) as followed
earlier [18]. The slides were then washed in PBS and incu-
bated with antirabbit conjugated Alexa-ﬂuor 488 (Molecular
probes,CA).Sectionswerephotographedasdescribedearlier
[18].
To conﬁrm the immunoﬂuorescence ﬁndings, western
blot was performed using three of each control and HIVE2 Pathology Research International
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Figure 1: Immunoﬂuorescence study of aspartoacylase in the brain of patients with HIVE. Aspartoacylase protein is reduced in the fore
brain of HIVE patients compared to the control (magniﬁcation, 20x).
brain samples. Three brain samples of each control and
HIVE were homogenized in lysis buﬀer and western blot
was performed as followed earlier [19]. Fifteen-microgram
protein from control and HIVE brains was loaded onto a
12%gelandtheproteintransferrednitrocellulosemembrane
was blocked with 5% blocking buﬀer. Then the membrane
was incubated with ASPA antibody (Santa Cruz, CA) 1:200
dilution. After washing with PBS, membrane was incubated
withanti-rabbitHRPantibody(Invitrogen,CA).Theprotein
band was detected using supersignal west pico chemilumi-
nescent substrate (Fisher scientiﬁc, IL) and photographed
as described earlier [19]. Density of the bands was also
measured as described earlier [19]. Statistical analysis was
performed using ANOVA. P<0.05 was considered as
signiﬁcant.
3. Results andDiscussion
Immunostaining of the HIVE brain white matter showed
reduced level of ASPA compared to the control (Figure 1).
Theseﬂuorescentcellswerecolocalizedwitholigodendrocyte
marker (Data not shown). Western blot study also further
conﬁrmed the reduced level of ASPA in HIVE brain com-
pared to the control (Figure 2). Density analysis of the bands
showed that two-tailed P value was 0.02.
HIV has been a devastating disease over decades and
white matter degeneration is also reported [20, 21], however,
ASPA contribution in the white matter degeneration is not
known. ASPA is mainly synthesized in oligodendrocytes [1,
2]andareducedlevelofASPAimpedesmyelinationandthus
leads to axonal damage [1, 2, 22, 23].
Human immunodeﬁciency virus infection starts from
periphery and subsequently enters the central nervous
system but neurological symptoms occur years later. Axonal
damage is reported in the brain with HIVE [24, 25].
Monogene alters other genes expression to contribute in
disease pathophysiology [2]. HIV is capable of inserting with
genomic DNA [26]. This insertion would impede function
of other genes. Thus, deﬁciency of ASPA in the brain of
patients with HIVE observed in the present study suggests
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Figure 2: Western blot study of aspartoacylase protein in the brain
of patients with HIVE. (a) Aspartoacylase protein was deﬁcient
in the brain of patients with HIVE compared to the control. (b)
Density analysis of the band showed reduced amount of ASPA
proteininthebrainwithHIVEcomparedtothecontrolbrain.Two-
tailed P value was 0.02.
that HIVE condition aﬀects ASPA to contribute in myelin
loss and axonal damage seen in the disease.
In conclusion, HIVE condition aﬀects ASPA to con-
tribute in axonal damage seen in the disease.
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